Advertisement

Anticoagulants in myocardial infarction

Acute and long-term therapy
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      There is complete agreement that anticoagulants have a definite place in the management of acute coronary thrombosis with myocardial infarction. There is no disagreement as to the principle and value of the treatment, but only as to its application in particular cases. The question is not, to treat or not to treat; but whom to treat.
      Data compiled over the past ten years attest to the usefulness of anticoagulants in short-term treatment. The anticoagulant drugs now available are effective, but there is still something to be desired. Complications are uncommon, and rarely serious, in “good risk” cases. In “poor risk” cases they occur with greater frequency and are more serious.
      Long-term anticoagulant treatment is feasible and should be initiated if indications for its use are present. From personal experience with long-term therapy, as well as the experience of many other workers, it appears that its value is more than coincidence. It is not too optimistic to feel that long-term anticoagulant treatment may open the door of future medical activity heretofore shackled and imprisoned, bringing freedom to the healing hand and hope to those with chronic thromboembolic disease.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Arieff A.J.
        • Pyzik S.W.
        Paraplegia following or associated with excessive dicumarol therapy.
        Quart. Bull. Northwestern Univ. M. School. 1954; 28: 221
        • Bay E.
        • Adams W.R.
        • Jones R.J.
        • Page R.G.
        • Seide M.
        The use of anticoagulant drugs in ambulatory patients.
        Circulation. 1954; 9: 741
        • Brown K.W.G.
        • MacMillen R.L.
        The choice of an anticoagulant.
        Am. J. M. Sc. 1954; 227: 526
        • Campbell H.A.
        • Link K.P.
        Studies on the hemorrhagic sweet clover disease. IV. The isolation and crystallization of the hemorrhagic agent.
        J. Biol. Chem. 1941; 138: 21
        • Chatterjea J.B.
        • Salomon L.
        Antagonistic effect of ACTH and Cortisone on anticoagulant activity of ethyl biscoumacetate.
        Brit. M. J. 1954; 2: 790
        • Clatanoff D.V.
        • Meyer O.O.
        Further observations on use of warfarin sodium in anti-coagulant therapy.
        A.M.A. Arch. Int. Med. 1956; 97: 753
        • Duff I.F.
        • Shull W.H.
        Fatal hemorrhage in dicumarol poisoning with report of necropsy.
        J.A.M.A. 1949; 139: 762
        • Engelberg H.
        • Kuhn R.
        • Steinman M.
        A controlled study of the effect of intermittent heparin therapy on the course of human coronary atherosclerosis.
        Circulation. 1956; 13: 489
        • Foley W.T.
        • Wright I.S.
        Long-term anticoagulant therapy for cardiovascular diseases.
        Am. J. M. Sc. 1949; 217: 136
        • Goodman L.
        • Gilman A.
        The Pharmacological Basis of Therapeutics. Macmillan, New York1956
        • Halperin M.M.
        • Lemberg L.
        • Belle M.
        • Eichert H.
        Selective use of anticoagulants in acute myocardial infarction based on initial prognosis.
        Ann. Int. Med. 1954; 41: 942
        • Howell W.H.
        • Holt E.
        Two new factors in blood coagulation, heparin and proantithrombin.
        Am. J. Physiol. 1918; 47: 328
        • Izzo P.
        • Stevens R.C.
        • Tomsykoski A.J.
        • Rodriquez C.E.
        Hemopericardium associated with anticoagulant therapy.
        A.M.A. Arch. Int. Med. 1953; 92: 350
        • Keys J.W.
        • Drake H.D.
        • James T.N.
        • Smith F.J.
        Survival rates after myocardial infarctions with and without long-term anticoagulant therapy.
        Am. J. M. Sc. 1953; 226: 607
        • Kirkeby K.
        Agranulocytosis following treatment with phenylindandione.
        Lancet. 1954; 2: 580
        • Lee K.T.
        • O'Neal R.M.
        Anticoagulant therapy of myocardial infarction.
        Am. J. Med. 1956; 21: 555
        • Makous N.
        • Van der Veer J.B.
        Severe drug sensitivity reaction to phenindione (phenylindandione).
        J.A.M.A. 1954; 155: 739
        • McLean J.
        The thromboplastic action of cephalin.
        Am. J. Physiol. 1916; 41: 250
        • Neill E.C.
        • Moon R.Y.
        • Van der Veer J.B.
        Clinical evaluation of a new oral anticoagulant “Sintrom”.
        Circulation. 1957; 15: 713
        • Nichol E.S.
        The risk of hemorrhage in anticoagulant therapy.
        Ann. West. Med. & Surg. 1950; 4: 71
        • Nichol E.S.
        • Fassett D.W.
        An attempt to forestall acute coronary thrombosis: Preliminary note on the continuous use of dicumarol.
        South. M. J. 1947; 40: 631
        • Peel A.A.F.
        Selection for anticoagulant therapy in cardiac infarction using the heparin retarded coagulation time.
        Brit. Heart J. 1956; 18: 378
        • Prinzmetal M.
        • Weiner S.M.
        • Bhayan M.C.
        Mild myocardial infarction. Clinical features and new methods of management.
        Am. J. Card. 1958; 1: 26
        • Prinzmetal M.
        Mild Myocardial Infarction.
        in: Read at Interim Meeting, American College of Cardiology. Nov., 1956 (Pittsburgh, Pa.)
        • Rosenthal R.L.
        Blood coagulation in leucemia and polycythemia; value of the heparin clotting time and clot retraction rate.
        J. Lab. & Clin. Med. 1949; 34: 1321
        • Russek H.I.
        • Zohman B.L.
        Chances for survival in acute myocardial infarction.
        J.A.M.A. 1954; 156: 765
        • Russek H.I.
        • Zohman B.L.
        Immediate prognosis in acute myocardial infarction.
        Tr. Am. Coll. Cardiology. 1954; 4: 135
        • Russek H.I.
        • Zohman B.L.
        “Selective” versus routine use of anticoagulants in acute myocardial infarction.
        J.A.M.A. 1954; 156: 12
        • Schnur S.
        Mortality rates in acute myocardial infarction. II. Proposed method for measuring quantitatively severity of illness on admission to hospital.
        Ann. Int. Med. 1953; 39: 1018
        • Shapiro S.
        Long-term anticoagulant therapy.
        M. Clin. North America. 1953; 37: 659
        • Shapiro S.
        • Spitzer J.M.
        Use of Cepevit (ascorbic acid plus “P” factors) in drug induced hypoprothrombinemia.
        Angiology. 1954; 5: 64
        • Solandt D.Y.
        • Best C.H.
        Heparin and coronary thrombosis in experimental animals.
        Lancet. 1938; 2: 130
        • Solandt D.Y.
        • Nassim R.
        • Best C.H.
        Production and prevention of cardiac mural thrombosis in dogs.
        Lancet. 1939; 2: 592
        • Suzman M.M.
        • Ruskin H.D.
        • Goldberg B.
        An evaluation of the effect of continuous long-term anticoagulant therapy on the prognosis of myocardial infarction.
        Circulation. 1955; 12: 338
        • Tronnberg G.
        Hyaluronidase in intramuscular administration of heparin.
        Acta chir. scandinav. 1954; 108: 158
        • Tullock J.
        • Wright I.S.
        Long-term anticoagulant therapy.
        Circulation. 1954; 9: 823
        • Waldron B.R.
        • Fennell Jr., R.H.
        • Castleman B.
        • Bland E.F.
        Myocardial rupture and hemopericardium associated with anticoagulant therapy.
        New England J. Med. 1954; 251: 892
        • Wright L.S.
        Experiences with Dicumarol in the treatment of coronary thrombosis.
        in: Proc. Am. Fed. Clin. Res.2. 1945: 101
        • Wright I.S.
        • Bourgain R.H.
        • Foley W.T.
        • McDevitt E.
        • Gross C.
        • Burke B.
        • Simon E.
        • Lieberman J.
        • Symond C.
        • Huebner R.
        Long-term anticoagulant therapy.
        Circulation. 1954; 9: 748
        • Wright I.S.
        • Marple C.D.
        • Beck D.F.
        Myocardial Infarction: Its Clinical Manifestations and Treatment with Anticoagulants; A Study of 1,031 Cases. Grune and Stratton, New York1954
        • Wright I.S.
        An evaluation of the use of anticoagulant therapy in cardio-vascular diseases.
        Tr. & Stud. Coll. Physicians, Philadelphia. 1947; 15: 15